Black Bird Biotech Stock Price, News & Analysis
Company Description
Black Bird Biotech (OTC Link: BBBT) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $178.5K.
BBBT stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of BBBT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Black Bird Biotech (BBBT) stock last traded at $0.0000. At a market capitalization of $178.5K, BBBT is classified as a micro-cap stock with approximately 984.0M shares outstanding.
Latest News
Black Bird Biotech has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include management. View all BBBT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BBBT Company Profile & Sector Positioning
Black Bird Biotech (BBBT) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BBBT often look at related companies in the same sector, including Green Rain Energy Holdings Inc (NWPND), Xebra Brands (XBRAF), Centr Brands (CNTRF), Pineapple Express Cannabis Co (PNXP), and Canntab Therapeutics Ltd (CTABF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BBBT's relative position within its industry.